[Clinical experiences with hexamethylenebis (N-methylcarbamoyl-m-trimethylammonium-phenol in pseudoparalytic myasthenia gravis].
D002800:Cholinesterase Inhibitors; D006801:Humans; D009157:Myasthenia Gravis; D009388:Neostigmine / Q000031:analogs & derivatives; D019800:Phenol; D010636:Phenols
D002800:Cholinesterase Inhibitors; D010636:Phenols; D019800:Phenol; D009388:Neostigmine
CHOLINESTERASE/antagonists; NEOSTIGMINE/derivatives
Klinische Erfahrungen mit Hexamethylenbis-(N-methyl-carbaminoyl-m-Trimethylammoniumphenol) (BC 40) bei Myasthenia gravis pseudoparalytica.